vs
Cytek Biosciences, Inc.（CTKB）与MERCANTILE BANK CORP（MBWM）财务数据对比。点击上方公司名可切换其他公司
MERCANTILE BANK CORP的季度营收约是Cytek Biosciences, Inc.的1.1倍（$67.6M vs $62.1M），MERCANTILE BANK CORP净利率更高（33.6% vs -70.9%，领先104.5%），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 9.1%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
泰米尔纳德商业银行（TMB）是一家印度银行，总部位于泰米尔纳德邦杜蒂戈林。该行始建于1921年，最初名为纳达尔银行，1962年11月更名为泰米尔纳德商业银行，以拓展纳达尔社群以外的业务。目前该银行在印度全境拥有600家全功能网点、12个区域办事处及各类配套服务中心与自助设施。
CTKB vs MBWM — 直观对比
营收规模更大
MBWM
是对方的1.1倍
$62.1M
净利率更高
MBWM
高出104.5%
-70.9%
两年增速更快
CTKB
近两年复合增速
9.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $67.6M |
| 净利润 | $-44.1M | $22.7M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | — |
| 净利率 | -70.9% | 33.6% |
| 营收同比 | 8.1% | — |
| 净利润同比 | -557.1% | 16.1% |
| 每股收益（稀释后） | — | $1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBMBWM
| Q1 26 | — | $67.6M | ||
| Q4 25 | $62.1M | $62.1M | ||
| Q3 25 | $52.3M | $62.4M | ||
| Q2 25 | $45.6M | $60.9M | ||
| Q1 25 | $41.5M | $57.3M | ||
| Q4 24 | $57.5M | $58.5M | ||
| Q3 24 | $51.5M | $58.0M | ||
| Q2 24 | $46.6M | $56.8M |
净利润CTKBMBWM
| Q1 26 | — | $22.7M | ||
| Q4 25 | $-44.1M | $22.8M | ||
| Q3 25 | $-5.5M | $23.8M | ||
| Q2 25 | $-5.6M | $22.6M | ||
| Q1 25 | $-11.4M | $19.5M | ||
| Q4 24 | $9.6M | $19.6M | ||
| Q3 24 | $941.0K | $19.6M | ||
| Q2 24 | $-10.4M | $18.8M |
毛利率CTKBMBWM
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
营业利润率CTKBMBWM
| Q1 26 | — | — | ||
| Q4 25 | -9.0% | 42.0% | ||
| Q3 25 | -17.6% | 44.0% | ||
| Q2 25 | -23.3% | 42.6% | ||
| Q1 25 | -36.1% | 42.0% | ||
| Q4 24 | 5.2% | 39.7% | ||
| Q3 24 | -8.2% | 42.4% | ||
| Q2 24 | -18.3% | 41.4% |
净利率CTKBMBWM
| Q1 26 | — | 33.6% | ||
| Q4 25 | -70.9% | 36.8% | ||
| Q3 25 | -10.5% | 38.1% | ||
| Q2 25 | -12.2% | 37.1% | ||
| Q1 25 | -27.5% | 34.1% | ||
| Q4 24 | 16.8% | 33.5% | ||
| Q3 24 | 1.8% | 33.8% | ||
| Q2 24 | -22.4% | 33.1% |
每股收益（稀释后）CTKBMBWM
| Q1 26 | — | $1.32 | ||
| Q4 25 | — | $1.41 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $1.39 | ||
| Q1 25 | — | $1.21 | ||
| Q4 24 | — | $1.20 | ||
| Q3 24 | — | $1.22 | ||
| Q2 24 | — | $1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | — |
| 总债务越低越好 | — | $1.5M |
| 股东权益账面价值 | $341.7M | $736.9M |
| 总资产 | $461.5M | $6.9B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资CTKBMBWM
| Q1 26 | — | — | ||
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — |
总债务CTKBMBWM
| Q1 26 | — | $1.5M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CTKBMBWM
| Q1 26 | — | $736.9M | ||
| Q4 25 | $341.7M | $724.9M | ||
| Q3 25 | $378.6M | $657.6M | ||
| Q2 25 | $377.6M | $631.5M | ||
| Q1 25 | $379.6M | $608.3M | ||
| Q4 24 | $395.7M | $584.5M | ||
| Q3 24 | $385.5M | $583.3M | ||
| Q2 24 | $389.1M | $551.2M |
总资产CTKBMBWM
| Q1 26 | — | $6.9B | ||
| Q4 25 | $461.5M | $6.8B | ||
| Q3 25 | $494.9M | $6.3B | ||
| Q2 25 | $493.3M | $6.2B | ||
| Q1 25 | $482.6M | $6.1B | ||
| Q4 24 | $499.5M | $6.1B | ||
| Q3 24 | $491.2M | $5.9B | ||
| Q2 24 | $483.7M | $5.6B |
负债/权益比CTKBMBWM
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | — |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -2.9% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | — |
8季度趋势，按日历期对齐
经营现金流CTKBMBWM
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $18.0M | ||
| Q3 25 | $-3.9M | $23.1M | ||
| Q2 25 | $108.0K | $-7.8M | ||
| Q1 25 | $-125.0K | $-3.0M | ||
| Q4 24 | $2.0M | $101.1M | ||
| Q3 24 | $13.2M | $-8.1M | ||
| Q2 24 | $6.2M | $9.1M |
自由现金流CTKBMBWM
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — |
自由现金流率CTKBMBWM
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — |
资本支出强度CTKBMBWM
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — |
现金转化率CTKBMBWM
| Q1 26 | — | — | ||
| Q4 25 | — | 0.79× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | -0.35× | ||
| Q1 25 | — | -0.15× | ||
| Q4 24 | 0.21× | 5.15× | ||
| Q3 24 | 14.05× | -0.41× | ||
| Q2 24 | — | 0.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MBWM
| Net Interest Income | $55.9M | 83% |
| Noninterest Income | $11.7M | 17% |
